New Associations of the Genetic Polymorphisms in Nicotinic Receptor Genes with the Risk of Lung Cancer

Overview

Journal Life Sci

Publisher Elsevier

Specialties Biochemistry
Biology
Physiology

Date 2012 Jan 28

PMID 22280835

Citations 12

Authors

Anna Chikova

Hans-Ulrich Bernard

Igor B Shchepotin

Sergei A Grando

Affiliations

Soon will be listed here.

Abstract

Aims: Previous studies revealed association of lung cancer risk with single nucleotide polymorphisms (SNPs) in chromosome 15q25 region containing CHRNA5-CHRNA3-CHRNB4 nicotinic acetylcholine receptor (nAChR) subunit gene cluster. The genetic variations in other lung nAChRs remained unknown. In this study, we perform case-control analysis of CHRNA9 and CHRNA3 genes using 340 non-small cell lung cancer cases and 435 controls.

Main Methods: All exons, 3'UTR, intron 1 and parts of other introns surrounding exons 2-5 of CHRNA9 gene as well as exons 2, 3 of CHRNA3 gene and parts of surrounding intronic regions were sequenced. The study was controlled for gender, age and ethnicity related differences. Each SNP in analyzed groups was assessed by allele frequency, genotype distribution and haplotype analysis.

Key Findings: The case-control analysis revealed that an increased risk is associated with two SNPs in CHRNA9, rs56159866 and rs6819385, and one in CHRNA3, rs8040868. The risk was reduced for three SNPs in CHRNA9, rs55998310, rs56291234, and newly discovered rs182073550, and also in carriers of the haplotype NP_060051.2 containing ancestral N442 variant of α9.

Significance: The nonsynonymous substitutions can produce receptors exhibiting unique ligand-binding and downstream signaling characteristics, synonymous as well all intronic SNPs may affect protein production at the transcriptional and/or translational levels, or just manifest association with cancer by genetic linkage to other alleles. Elucidation of the mechanisms by which individual genetic variations in α9 affect predisposition to lung cancer may lead to development of personalized approaches to cancer prevention and treatment as well as protection against tobacco consumption.

Citing Articles

α9-Containing Nicotinic Receptors in Cancer.

Pucci S, Zoli M, Clementi F, Gotti C Front Cell Neurosci. 2022; 15:805123.

PMID: 35126059 PMC: 8814915. DOI: 10.3389/fncel.2021.805123.

Study on polymorphisms in CHRNA5/CHRNA3/CHRNB4 gene cluster and the associated with the risk of non-small cell lung cancer.

Sun Y, Li J, Zheng C, Zhou B Oncotarget. 2018; 9(2):2435-2444.

PMID: 29416783 PMC: 5788651. DOI: 10.18632/oncotarget.23459.

Two susceptibility variants for COPD are genetic determinants of emphysema and chest computed tomography manifestations in Chinese patients.

Zhao Z, Jiang C, Zhao D, Li Y, Liang C, Liu W Int J Chron Obstruct Pulmon Dis. 2017; 12:1447-1455.

PMID: 28553097 PMC: 5439970. DOI: 10.2147/COPD.S134010.

αO-Conotoxin GeXIVA disulfide bond isomers exhibit differential sensitivity for various nicotinic acetylcholine receptors but retain potency and selectivity for the human α9α10 subtype.

Zhangsun D, Zhu X, Kaas Q, Wu Y, Craik D, McIntosh J Neuropharmacology. 2017; 127:243-252.

PMID: 28416445 PMC: 6029978. DOI: 10.1016/j.neuropharm.2017.04.015.

Proteins and chemical chaperones involved in neuronal nicotinic receptor expression and function: an update.

Crespi A, Colombo S, Gotti C Br J Pharmacol. 2017; 175(11):1869-1879.

PMID: 28294298 PMC: 5978959. DOI: 10.1111/bph.13777.

References

Nguyen V, Ndoye A, Grando S . Novel human alpha9 acetylcholine receptor regulating keratinocyte adhesion is targeted by Pemphigus vulgaris autoimmunity. Am J Pathol. 2000; 157(4):1377-91. PMC: 1850172. DOI: 10.1016/s0002-9440(10)64651-2. View

Duarte R, Paschoal M . Molecular markers in lung cancer: prognostic role and relationship to smoking. J Bras Pneumol. 2007; 32(1):56-65. DOI: 10.1590/s1806-37132006000100012. View

Shiraishi K, Kohno T, Kunitoh H, Watanabe S, Goto K, Nishiwaki Y . Contribution of nicotine acetylcholine receptor polymorphisms to lung cancer risk in a smoking-independent manner in the Japanese. Carcinogenesis. 2008; 30(1):65-70. DOI: 10.1093/carcin/bgn257. View

Klapproth H, Reinheimer T, Metzen J, Munch M, Bittinger F, Kirkpatrick C . Non-neuronal acetylcholine, a signalling molecule synthezised by surface cells of rat and man. Naunyn Schmiedebergs Arch Pharmacol. 1997; 355(4):515-23. DOI: 10.1007/pl00004977. View

Schuller H, Nylen E, Park P, Becker K . Nicotine, acetylcholine and bombesin are trophic growth factors in neuroendocrine cell lines derived from experimental hamster lung tumors. Life Sci. 1990; 47(6):571-8. DOI: 10.1016/0024-3205(90)90618-2. View

Wu C, Lee C, Ho Y . Nicotinic acetylcholine receptor-based blockade: applications of molecular targets for cancer therapy. Clin Cancer Res. 2011; 17(11):3533-41. DOI: 10.1158/1078-0432.CCR-10-2434. View

Villeneuve P, Mao Y . Lifetime probability of developing lung cancer, by smoking status, Canada. Can J Public Health. 1994; 85(6):385-8. View

Cattaneo M, DAtri F, Vicentini L . Mechanisms of mitogen-activated protein kinase activation by nicotine in small-cell lung carcinoma cells. Biochem J. 1998; 328 ( Pt 2):499-503. PMC: 1218947. DOI: 10.1042/bj3280499. View

Sherva R, Kranzler H, Yu Y, Logue M, Poling J, Arias A . Variation in nicotinic acetylcholine receptor genes is associated with multiple substance dependence phenotypes. Neuropsychopharmacology. 2010; 35(9):1921-31. PMC: 3055642. DOI: 10.1038/npp.2010.64. View

10.

Valor L, Castillo M, Ortiz J, Criado M . Transcriptional regulation by activation and repression elements located at the 5'-noncoding region of the human alpha9 nicotinic receptor subunit gene. J Biol Chem. 2003; 278(39):37249-55. DOI: 10.1074/jbc.M307043200. View

11.

Chikova A, Grando S . Naturally occurring variants of human Α9 nicotinic receptor differentially affect bronchial cell proliferation and transformation. PLoS One. 2011; 6(11):e27978. PMC: 3220719. DOI: 10.1371/journal.pone.0027978. View

12.

West K, Brognard J, Clark A, Linnoila I, Yang X, Swain S . Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest. 2003; 111(1):81-90. PMC: 151834. DOI: 10.1172/JCI16147. View

13.

Tournier J, Birembaut P . Nicotinic acetylcholine receptors and predisposition to lung cancer. Curr Opin Oncol. 2010; 23(1):83-7. DOI: 10.1097/CCO.0b013e3283412ea1. View

14.

Le Marchand L, Derby K, Murphy S, Hecht S, Hatsukami D, Carmella S . Smokers with the CHRNA lung cancer-associated variants are exposed to higher levels of nicotine equivalents and a carcinogenic tobacco-specific nitrosamine. Cancer Res. 2008; 68(22):9137-40. PMC: 2587068. DOI: 10.1158/0008-5472.CAN-08-2271. View

15.

Liu Y, Liu P, Wen W, James M, Wang Y, Bailey-Wilson J . Haplotype and cell proliferation analyses of candidate lung cancer susceptibility genes on chromosome 15q24-25.1. Cancer Res. 2009; 69(19):7844-50. PMC: 2846106. DOI: 10.1158/0008-5472.CAN-09-1833. View

16.

Linnoila R . From nicotine to breast cancer, implications of cholinergic receptor pathway. J Natl Cancer Inst. 2010; 102(17):1298-9. DOI: 10.1093/jnci/djq314. View

17.

Song P, Sekhon H, Jia Y, Keller J, Blusztajn J, Mark G . Acetylcholine is synthesized by and acts as an autocrine growth factor for small cell lung carcinoma. Cancer Res. 2003; 63(1):214-21. View

18.

Maneckjee R, Minna J . Opioids induce while nicotine suppresses apoptosis in human lung cancer cells. Cell Growth Differ. 1994; 5(10):1033-40. View

19.

Lee C, Huang C, Chen C, Tu S, Wang Y, Chang Y . Overexpression and activation of the alpha9-nicotinic receptor during tumorigenesis in human breast epithelial cells. J Natl Cancer Inst. 2010; 102(17):1322-35. DOI: 10.1093/jnci/djq300. View

20.

Greenbaum L, Kanyas K, Karni O, Merbl Y, Olender T, Horowitz A . Why do young women smoke? I. Direct and interactive effects of environment, psychological characteristics and nicotinic cholinergic receptor genes. Mol Psychiatry. 2005; 11(3):312-22, 223. DOI: 10.1038/sj.mp.4001774. View